Lucid Diligence Brief: Sprint Bioscience sells TREX1 program to Gilead
Lucid Diligence Brief: Sprint Bioscience sells TREX1 program to Gilead…
Lucid Diligence Brief: Vaximm VXM01 License Term Sheet with BCM Europe
Lucid Diligence Brief: Vaximm VXM01 License Term Sheet with BCM Europe…
Lucid Diligence Brief: Aspen Neuroscience $115M Series C
Lucid Diligence Brief: Aspen Neuroscience $115M Series C Professional audiences…
Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home Alzheimer’s blood collection
Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home…
Lucid Diligence Brief: Abbott to acquire Exact Sciences
Lucid Diligence Brief: Abbott to acquire Exact Sciences Professional audiences…
Lucid Diligence Brief: Tempest Therapeutics and Factor Bioscience dual-CAR T deal
Lucid Diligence Brief: Tempest Therapeutics and Factor Bioscience dual-CAR T…
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics…
Lucid Diligence Brief: Merck to acquire Cidara Therapeutics
Lucid Diligence Brief: Merck to acquire Cidara Therapeutics Professional…
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG platform
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG…
Lucid Diligence Brief: T-Therapeutics Series A extension to $91m
Lucid Diligence Brief: T-Therapeutics Series A extension to $91m Professional…
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled clinical-trial recruitment
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled…
Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for precision neurology and BCI
Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for…